amdinocillin has been researched along with Escherichia coli Infections in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (32.61) | 18.7374 |
1990's | 2 (4.35) | 18.2507 |
2000's | 5 (10.87) | 29.6817 |
2010's | 16 (34.78) | 24.3611 |
2020's | 8 (17.39) | 2.80 |
Authors | Studies |
---|---|
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Cars, O; Löwdin, E; Melhus, A; Tängdén, T | 1 |
Bjerklund Johansen, TE; Cai, T; Livermore, DM; Mushtaq, S; Tutone, M | 1 |
Andersen, TE; Grønnemose, RB; Lund, L; Palarasah, Y; Stærk, K | 1 |
Frimodt-Møller, N; Kahlmeter, G; Larsen, AR; Simonsen, GS | 1 |
Abu Sin, M; Eckmanns, T; Klingeberg, A; Kramme, E; Kresken, M; Werner, G; Wohlfarth, E | 1 |
Frimodt-Møller, N; Hansen, KH; Hertz, FB; Jansåker, F; Knudsen, JD; Nielsen, JB; Nielsen, KL; Schønning, K | 1 |
Doi, Y; Fang, C; Guo, Q; Hu, G; Li, D; Shen, Z; Wang, M; Yin, M; Zhang, X; Zhang, Y | 1 |
Andersson, DI; Fatsis-Kavalopoulos, N; Kreuger, J; Roemhild, R; Tang, PC | 1 |
Antsupova, V; Arpi, M; Boel, JB; Holzknecht, BJ; Jarløv, JO; Knudsen, JD | 1 |
Crowe, A; Jardine, D; Olenski, M; Poy Lorenzo, YS | 1 |
Bidet, P; Birgy, A; Bonacorsi, S; Caseris, M; Delecourt, M; Desselas, E; Geslain, G; Magnan, M; Mariani-Kurkdjian, P | 1 |
Körber-Irrgang, B; Kresken, M; Naber, KG | 1 |
Andersson, DI; Thulin, E; Thulin, M | 1 |
Bigaillon, C; Bousquet, A; Bugier, S; De Briel, D; Delacour, H; Larréché, S; Mérens, A; Valade, E; Weber, P | 1 |
Fredheim, EGA; Johnsen, PJ; Kloos, J; Podnecky, NL; Primicerio, R; Roberts, AP; Rozen, DE; Samuelsen, Ø; Sørum, V | 1 |
Andersson, DI; Thulin, E | 1 |
Granholm, S; Johansson, A; Kahlmeter, G; Poulsen, HO; Sundqvist, M | 1 |
Jenum, PA; Jørgensen, SB; Liestøl, K; Sundsfjord, A; Søraas, A | 1 |
Ferry, BM; Ferry, SA; Holm, SE; Monsen, TJ | 1 |
Ahmad Murad, K; Chen, YT; Ng, LS; Park, JJ; Seah, JT; Tan, TY | 1 |
Cattoen, C; Descamps, D; Duployez, C; Loiez, C; Vachée, A; Wallet, F | 1 |
Fennell, JP; Kavanagh, S; Manecksha, R; O'Kelly, F; Thornhill, J | 1 |
Howe, RA; Macfarlane, L; Walsh, TR; Wootton, M | 1 |
Galani, I; Giamarellou, H; Katsarolis, I; Lampri, N; Petrikkos, G; Poulakou, G; Souli, M | 1 |
Espersen, F; Frimodt-Møller, N; Kerrn, MB | 2 |
Espersen, F; Frimodt-Moller, N; Menday, P; Skov, R | 1 |
Habte, D; Stintzing, G; Thorén, A; Wadström, T; Wolde-Mariam, T | 1 |
Barbour, AG; Mayer, LW; Spratt, BG | 1 |
Beskid, G; Cleeland, R; Grimm, LM; McCracken, GH; Nelson, JD; Schaad, UB | 1 |
Borowski, J; Zaremba, M; Zukowska-Nytko, K | 1 |
Black, FT; Christensen, O; Gaarslev, K; Orskov, F; Orskov, I; Stenderup, A; Stenderup, J | 1 |
Cleeland, R; Kramer, MJ; Mauriz, YR; Robertson, TL; Timmes, MD | 1 |
Gordin, FM; Sande, MA | 1 |
Farrar, WE; Rotstein, C | 1 |
Howells, CH; Menday, AP; O'Dowd, TC; Ribeiro, CD; Smail, JE | 1 |
Banke, S; Bruno, AM; Carlsson, M; Cronberg, S; Elmrud, H; Elowsson, S; Josefsson, K; Lindholm, AC; Montelius, H; Neringer, R | 1 |
Jarlier, V; Sougakoff, W | 1 |
Frimodt-Møller, N; Ravn, TJ | 1 |
Berger, RE; Mack, LA; Opheim, KE; See, WA; Tartaglione, TA; Taylor, TO | 1 |
Cleeland, R; Costerton, JW; Khoury, AE; Morck, DW; Nickel, JC; Olson, ME | 1 |
Henrion, R; Vige, P | 1 |
Antipov, AV | 1 |
Lisitsa, LI; Rudzit, EA; Starkov, MV; Zinchenko, TA | 1 |
Campbell-Brown, M; McFadyen, IR; Seal, DV; Stephenson, M | 1 |
1 review(s) available for amdinocillin and Escherichia coli Infections
Article | Year |
---|---|
Amdinocillin therapy of experimental animal infections.
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meningitis; Penicillanic Acid | 1983 |
6 trial(s) available for amdinocillin and Escherichia coli Infections
Article | Year |
---|---|
Mecillinam resistance and outcome of pivmecillinam treatment in uncomplicated lower urinary tract infection in women.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amdinocillin; Amdinocillin Pivoxil; Anti-Infective Agents, Urinary; Double-Blind Method; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Staphylococcal Infections; Staphylococcus saprophyticus; Treatment Outcome; Urinary Tract Infections; Young Adult | 2014 |
Antibiotics in the treatment of gastroenteritis caused by enteropathogenic Escherichia coli.
Topics: Amdinocillin; Clinical Trials as Topic; Escherichia coli; Escherichia coli Infections; Female; Gastroenteritis; Humans; Infant; Infant, Newborn; Male; Penicillanic Acid; Serotyping; Sulfamethoxazole; Trimethoprim | 1980 |
Mecillinam, a new prophylactic for travellers' diarrhoea. A prospective double-blind study in tourists travelling to Egypt and the Far East.
Topics: Administration, Oral; Adult; Aged; Amdinocillin; Asia, Eastern; Diarrhea; Double-Blind Method; Doxycycline; Egypt; Escherichia coli; Escherichia coli Infections; Feces; Humans; Middle Aged; Penicillanic Acid; Penicillin Resistance; Prospective Studies; Salmonella; Salmonella Infections; Travel | 1983 |
A comparative trial of pivmecillinam/pivampicillin and amoxycillin/clavulanate in the therapy of urinary tract infection in a general practice population.
Topics: Adult; Aged; Amdinocillin; Amdinocillin Pivoxil; Amoxicillin; Ampicillin; Bacteriuria; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Escherichia coli Infections; Female; Humans; Middle Aged; Pivampicillin; Random Allocation | 1984 |
Ampicillin plus mecillinam vs. cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis.
Topics: Amdinocillin; Ampicillin; Cefadroxil; Cefotaxime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Humans; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Pyelonephritis | 1995 |
Single-dose treatment of bacteriuria in pregnancy.
Topics: Amdinocillin; Amdinocillin Pivoxil; Ampicillin; Bacteriuria; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Escherichia coli Infections; Female; Humans; Pivampicillin; Pregnancy; Pregnancy Complications, Infectious; Random Allocation | 1987 |
39 other study(ies) available for amdinocillin and Escherichia coli Infections
Article | Year |
---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sweden; Travel; White People; Young Adult | 2010 |
SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study.
Topics: Amdinocillin; Anti-Bacterial Agents; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Nitrofurantoin; Urinary Tract Infections | 2022 |
Intracellular uropathogenic Escherichia coli are undetectable in urinary bladders after oral mecillinam treatment: An experimental study in a pig model of cystitis.
Topics: Amdinocillin; Animals; Bacteria; Cystitis; Escherichia coli Infections; Humans; Mammals; Mice; Reinfection; Swine; Urinary Bladder; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |
Pivmecillinam, the paradigm of an antibiotic with low resistance rates in Escherichia coli urine isolates despite high consumption.
Topics: Amdinocillin; Amdinocillin Pivoxil; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Humans; Urinary Tract Infections | 2022 |
Letter to the editor: Antimicrobial resistance data and treatment guidelines - challenges in the context of urine samples and mecillinam testing.
Topics: Amdinocillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 2023 |
Mutational change of CTX-M-15 to CTX-M-127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient.
Topics: Amdinocillin; Amdinocillin Pivoxil; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genome, Bacterial; Genomics; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Phylogeny; Whole Genome Sequencing | 2019 |
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; China; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Plasmids | 2020 |
CombiANT: Antibiotic interaction testing made easy.
Topics: Algorithms; Amdinocillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Pseudomonas aeruginosa; Pseudomonas Infections; Reproducibility of Results; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim; Urinary Tract Infections | 2020 |
Intravenous mecillinam compared with other β-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract; Urinary Tract Infections | 2021 |
Mecillinam susceptibility in Victorian third generation cephalosporin-nonsusceptible Escherichia coli urinary isolates.
Topics: Amdinocillin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Urinary Tract Infections | 2021 |
A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
Topics: Amdinocillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; France; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Penicillinase; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Urinary Tract Infections | 2017 |
[In-vitro activity of mecillinam against urine isolates of Escherichia coli from outpatient departments in Germany].
Topics: Adult; Aged; Ambulatory Care; Amdinocillin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Germany; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Urine | 2017 |
Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteriuria; beta-Lactam Resistance; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Metabolomics; Microbial Sensitivity Tests; Mutation; Urinary Tract Infections | 2017 |
Clinical isolates of Escherichia coli solely resistant to mecillinam: prevalence and epidemiology.
Topics: Adult; Aged; Aged, 80 and over; Amdinocillin; Anti-Infective Agents, Urinary; Bacterial Proteins; beta-Lactam Resistance; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Multilocus Sequence Typing; Mutation; Polymerase Chain Reaction; Prevalence; Urinary Tract Infections; Urine | 2018 |
Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Predisposition to Disease; Genetic Variation; Humans; Microbial Sensitivity Tests; Models, Statistical; Multivariate Analysis; Mutation; Nitrofurantoin; Phylogeny; Trimethoprim; Urinary Tract Infections | 2018 |
Upregulation of PBP1B and LpoB in
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; Cytoskeletal Proteins; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Signal Transduction; Transcription, Genetic; Urinary Tract Infections | 2019 |
High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread.
Topics: Adolescent; Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Canada; Cluster Analysis; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; Female; Genetic Variation; Genotype; Humans; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Nitrofurantoin; Urinary Tract Infections; Young Adult | 2013 |
High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amdinocillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Male; Middle Aged; Treatment Failure; Urinary Tract Infections; Young Adult | 2014 |
In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Genotype; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Penicillins; Singapore; Trimethoprim; Urinary Tract Infections | 2016 |
In vitro susceptibility to mecillinam of Escherichia coli strains isolated from the urine of pregnant women.
Topics: Adult; Amdinocillin; Amdinocillin Pivoxil; Anti-Bacterial Agents; Asymptomatic Diseases; Bacterial Proteins; Bacteriuria; beta-Lactamases; Disk Diffusion Antimicrobial Tests; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Prodrugs; Prospective Studies; Urinary Tract Infections; Urine; Uropathogenic Escherichia coli | 2016 |
Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
Topics: Aged; Amdinocillin; Amdinocillin Pivoxil; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; General Practice; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitalization; Hospitals; Humans; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Nursing Homes; Pilot Projects; Prevalence; Prospective Studies; Risk Factors; Urinary Tract Infections | 2016 |
Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Wales | 2010 |
Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Community-Acquired Infections; DNA, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Greece; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Urinary Tract Infections | 2012 |
Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model.
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Area Under Curve; Colony Count, Microbial; Escherichia coli Infections; Female; Kidney; Mice; Microbial Sensitivity Tests; Sulfamethizole; Urinary Bladder; Urinary Tract Infections | 2003 |
Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole.
Topics: Administration, Oral; Amdinocillin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sulfamethizole; Urinary Tract Infections | 2004 |
Susceptibility testing of urinary isolates of Escherichia coli to mecillinam using NCCLS methodology.
Topics: Amdinocillin; Anti-Bacterial Agents; Citrobacter; Drug Resistance, Bacterial; Enterobacter; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Microbial Sensitivity Tests; Proteus; Reproducibility of Results; Urinary Tract Infections | 2005 |
Mecillinam resistance in Escherichia coli: dissociation of growth inhibition and morphologic change.
Topics: Adult; Amdinocillin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Humans; Male; Mutation; Penicillanic Acid; Penicillin Resistance; Phenotype; Sepsis | 1981 |
Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.
Topics: Amdinocillin; Ampicillin; Animals; Cephalosporins; Cephamycins; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Kinetics; Male; Meningitis; Mice; Moxalactam; Penicillanic Acid; Rabbits | 1982 |
[Studies on the combined effect of 6/N,N-hexyleneformamidine/-penicillanic acid (Preparation HX) and selected beta-lactam antibiotics on Escherichia coli and Salmonella. II. Studies in vivo].
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cephradine; Drug Synergism; Escherichia coli Infections; Mice; Mice, Inbred BALB C; Penicillanic Acid; Salmonella Infections | 1982 |
Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Bacteria; Drug Synergism; Escherichia coli; Escherichia coli Infections; Klebsiella pneumoniae; Mice; Microscopy, Electron, Scanning; Penicillanic Acid | 1983 |
Amdinocillin in combination with beta-lactam antibiotics for treatment of serious gram-negative infections.
Topics: Adolescent; Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid | 1983 |
Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
Topics: Amdinocillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests | 2000 |
Mecillinam in urinary tract infections and in septicaemia.
Topics: Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Drug Evaluation; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Penicillin Resistance; Sepsis; Urinary Tract Infections | 1979 |
Bacterial epididymitis in the rat: a model for assessing the impact of acute inflammation on epididymal antibiotic penetration.
Topics: Amdinocillin; Animals; Chromatography, High Pressure Liquid; Epididymis; Epididymitis; Escherichia coli Infections; Male; Rats; Rats, Inbred Strains; Time Factors; Ultrasonography | 1990 |
Amdinocillin treatment of catheter-associated bacteriuria in rabbits.
Topics: Amdinocillin; Animals; Bacteriuria; Catheters, Indwelling; Colony Count, Microbial; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Male; Microscopy, Electron, Scanning; Rabbits; Urinary Bladder; Urinary Catheterization | 1989 |
[Clinical study of pivmecillinam hydrochloride in lower urinary tract infections in pregnant women. Apropos of 44 cases].
Topics: Adult; Amdinocillin; Amdinocillin Pivoxil; Drug Administration Schedule; Drug Evaluation; Escherichia coli Infections; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Urinary Tract Infections | 1987 |
[Chemotherapeutic effectiveness of mecillinam and dioxidine in an experiment using polyresistant Escherichia coli].
Topics: Amdinocillin; Ampicillin; Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Escherichia coli Infections; Mice; Plasmids; Quinoxalines; Sepsis | 1987 |
[Comparative study of the chemotherapeutic effectiveness of mecillinam, ampicillin and their combination in coli bacillary pyelonephritis in rats].
Topics: Amdinocillin; Ampicillin; Animals; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Kidney; Pyelonephritis; Rats | 1986 |